Download Citation
Article Source:
High acceptability and viral suppression of patients on Dolutegravir-based first-line regimens in pilot sites in Uganda: A mixed-methods prospective cohort study
Nabitaka VM,
Nawaggi P,
Campbell J,
Conroy J,
Harwell J,
et al.
(2020)
High acceptability and viral suppression of patients on Dolutegravir-based first-line regimens in pilot sites in Uganda: A mixed-methods prospective cohort study.
PLOS ONE 15(5): e0232419.
https://doi.org/10.1371/journal.pone.0232419